Gastroenterology and Hepatology Board Review is an online video CME program that provides comprehensive coverage of the normal function, signs, symptoms, and diseases of the gastrointestinal organs. From the esophagus and stomach to the small intestine, colon, liver, pancreas, and biliary tract, this program offers in-depth lectures from recognized experts in the field.

Featuring over 40 one-hour lectures, this continuing medical education program offers an in-depth exploration of the latest advances and best practices in gastroenterology and hepatology. Each lecture is delivered by experts with extensive clinical experience who provide insights into decision-making processes, diagnostic procedures, medical therapy, surgical therapy, and procedural therapy. By combining scientific evidence and clinical judgment, these educators offer recommendations for the most appropriate care and improved patient outcomes.

Key Learning Objectives

The Gastroenterology and Hepatology Board Review program focuses on achieving the following learning objectives:

• Describe the clinical, endoscopic, and histopathologic features of eosinophilic esophagitis
• Summarize resuscitation, initial management, transfusion recommendations, and timing of endoscopy for peptic ulcer bleeding
• Explain the differential diagnosis, evaluation, and management of diarrhea
• Discuss inflammatory bowel disease diagnostic tools and work-up for appropriate patients
• Identify the risk factors that warrant screening for hepatitis C
• Recognize clinical trends in drug-induced liver injury
• List the possible pathogenic mechanisms of pancreatitis and how that informs drug targets and treatments
• Differentiate between acute calculous cholecystitis and acute acalculous cholecystitis
• List the core principles of obesity treatment
• Name the gastrointestinal manifestations of COVID-19 infection

Target Audience

The Gastroenterology and Hepatology Board Review program is designed for gastroenterologists, hepatologists, internists, fellows in gastroenterology, and internal medicine residents who have a keen interest in gastroenterology and hepatology. This program provides comprehensive education for both experienced professionals and those who are seeking to further their knowledge in the field.

Topics and Expert Speakers

The Gastroenterology and Hepatology Board Review program features a wide range of topics delivered by renowned experts in the field. Here are some of the key topics and speakers included in the program:

Esophagus

Gastroesophageal Reflux Disease (GERD) and Barrett’s Esophagus – Stuart Jon Spechler, MD

Esophageal Motility and Structural Disorders – Dustin A. Carlson, MD

Update in Eosinophilic Esophagitis and Eosinophilic Gastrointestinal Diseases – Evan S. Dellon, MD, MPH

Esophageal Cancer – Anil K. Rustgi, MD

Stomach and Small Intestine

Pathophysiology of Peptic Ulcer Disease – Helen M. Shields, MD

Peptic Ulcer Hemorrhage – Diagnosis and Management – Dennis M. Jensen, MD

Motility Disorders – Gastroparesis, Functional Dyspepsia, Ileus – Braden Kuo, MD, MSc

Malabsorption and Nutrition – Henry J. Binder, MD

Viral/Bacterial Gastroenteritis – Jason B. Harris, MD, MPH

Constipation and Diarrhea – Lawrence R. Schiller, MD

Celiac Disease and Gluten Sensitivity – Peter H. R. Green, MD

Colon

Diagnosis and Management of Clostridioides difficile Infections – Jessica R. Allegretti, MD, MPH

Inflammatory Bowel Disease – Anita Afzali, MD, MPH, MHCM

Irritable Bowel Syndrome – Walter W. Chan, MD, MPH, FACG, AGAF

Ischemic Bowel Disorders – A Case Based Approach – Paul Feuerstadt, MD

Colorectal Cancer Screening Strategies – Shilpa Grover, MD, MPH

An Update on Colorectal and Anal Cancers – Robert J. Mayer, MD

Hereditary Gastrointestinal Polyposis/Cancer Syndromes – John M. Carethers, MD, MACP

Liver – Hepatitis

Viral Hepatitis Overview – Raymond T. Chung, MD

Hepatitis B – Norah Terrault, MD, MPH

Hepatitis C – Ira M. Jacobson, MD

HIV – Viral Hepatitis Co-Infection – Kenneth E. Sherman, MD, PhD

Liver – General

Drug-Induced Liver Injury – Idiosyncratic (iDILI) and Acetaminophen – William M. Lee, MD, FACP, FAASLD, AGAF

Nonalcoholic Fatty Liver Disease – Stephen A. Harrison, MD

Alcohol-Associated Hepatitis – Jay Luther, MD

Autoimmune Liver Disorders – John M. Vierling, MD, FACP, FAASLD, AGAF

Genetic Liver Disorders – Kris V. Kowdley, MD, FACP

Hepatic Decompensation – Andrea Ewing Reid, MD, MPH

Hepatocellular Carcinoma – Augusto Villanueva, MD

Liver Transplantation – Thomas D. Schiano, MD

Liver Fibrosis – Don C. Rockey, MD

Pancreas

Acute Pancreatitis – Yasmin Genevieve Hernandez-Barco, MD

Recurrent-Chronic Pancreatitis – Evaluation and New Therapies – Steven D. Freedman, MD, PhD

Update in Pancreatic Cancer – William R. Brugge, MD

Biliary Tract

Gallstones, Gallbladder, and Biliary Tract Disease – Muthoka L. Mutinga, MD

Cholangiocarcinoma – Sumera I. Ilyas, MD

Special Topics

Gut Microbiome – Aonghus Lavelle, MD, PhD

Approach to Gastrointestinal Hemorrhage – John R. Saltzman, MD

A New Era in Obesity Treatment – Lee M. Kaplan, MD, PhD

COVID-19 – Gastrointestinal Manifestations – Thomas R. McCarty, MD

Gastrointestinal and Hepatic Toxicities of Checkpoint Blockade – Michael Dougan, MD

Acute Gastrointestinal Toxicity of Novel Anti-Cancer Therapies – Shilpa Grover, MD, MPH

Date of Original Release: August 31, 2023